Form 4: Frist Acquires Select Medical Stock

William H. Frist acquired 1,094 shares of Select Medical Holdings Corp. common stock on April 28, 2026, valued at $16.45 per share, as part of his director compensation.

Summary

• William H. Frist, a Director at Select Medical Holdings Corporation, acquired 1,094 shares of common stock on April 28, 2026.
• The acquisition was made under the Select Medical Holdings Corporation 2020 Equity Incentive Plan.
• These shares were issued in lieu of a quarterly retainer of $18,000.
• The transaction price was $16.45 per share, totaling an acquisition value of approximately $17,965.80.
• Following this transaction, Frist beneficially owns 306,266 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It represents a routine compensation transaction for a director and does not provide new financial performance data or strategic shifts.

Positives

• Director compensation is being provided in the form of equity, aligning management interests with shareholders.
• The acquisition of shares by a director indicates confidence in the company's future prospects.
• The transaction was executed under a pre-approved equity incentive plan, suggesting good corporate governance.

Negatives

• The value of the awarded stock ($17,965.80) is relatively small compared to the total beneficial ownership (306,266 shares), which might suggest a limited direct financial impact from this specific grant.

Risks

• The value of the awarded stock is subject to market fluctuations, which could impact the actual compensation received by the director.
• Potential for conflicts of interest if compensation structures are not carefully managed.

Future Outlook

This filing does not contain specific forward-looking statements or guidance. It reports a completed transaction related to director compensation.

Industry Context

StockSavvy.ai notes that the issuance of equity as director compensation is a common practice across the healthcare services industry, aiming to align executive interests with long-term shareholder value. This aligns with industry trends where companies utilize incentive plans to attract and retain experienced leadership.

Comparison to Industry Standards

• Many companies in the healthcare services sector, including competitors of Select Medical Holdings Corp., utilize equity-based compensation for their directors and executive officers.
• The structure of this award, replacing a cash retainer with stock, is a standard practice to conserve cash and incentivize performance.
• The value of the award ($18,000 equivalent) is within the typical range for director compensation in mid-cap healthcare companies, though specific benchmarks vary widely by company size and scope.

Corporate Governance

Related Party Transactions

• The acquisition of stock by Director William H. Frist is a related party transaction, as it involves compensation to a key insider.

Stakeholder Impact

• Shareholders: The issuance of stock aligns director interests with shareholders, potentially leading to better long-term decision-making. Dilution is minimal given the scale of the transaction relative to total shares outstanding.
• Employees: Indirectly impacted by director compensation decisions that affect company resources and strategic focus.
• Management: Reinforces the use of equity as a compensation tool, aligning with broader corporate strategy.

Next Steps

• Continued reporting of any future changes in beneficial ownership by William H. Frist.
• Ongoing adherence to the Select Medical Holdings Corporation 2020 Equity Incentive Plan for future compensation awards.

Key Dates

Keywords

Form 4, SEC Filing, William H. Frist, Select Medical Holdings Corp, SEM, Insider Trading, Director Compensation, Equity Incentive Plan, Stock Acquisition